semaglutide oral dosing Optimal and administration instructions for Semaglutide - Patients - Bloomsburg

Goldman Sachs forecasts that the global weight-loss drug market will reach USD 114 billion by 2030, an upward revision of 13% from last years estimate

Ozari Health publishes first-of-its-kind pricing analysis to help patients understand the real cost of GLP-1 medications.New York, NY, May 26, 2026 (GLOBE NEWSWIRE) -- Ozari Health, the New York-based telehealth company that makes GLP-1 weight loss medications accessible and affordable across the United States, has announced a pioneering study aimed at shedding light on the pricing dynamics of GLP-1 medications

The future of obesity treatment is being rewritten

The good

A new study from Norway by Tuominen and colleagues gives us a fresh roadmap for repurposing existing drugs to treat and to potentially modify the course of this disease

The percentage of Americans taking GLP-1 drugs such as Ozempic or Zepbound to lose weight has nearly quadrupled since 2024, according to a new survey by Gallup